Larson SM - Search Results

1

Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer.

Greco C, Nehmeh SA, Schöder H, Gönen M, Raphael B, Stambuk HE, Humm JL, Larson SM, Lee NY. Greco C, et al. Among authors: larson sm. Am J Clin Oncol. 2008 Oct;31(5):439-45. doi: 10.1097/COC.0b013e318168ef82. Am J Clin Oncol. 2008. PMID: 18838879

2

Advances in imaging.

Larson SM, Schwartz LH. Larson SM, et al. Semin Oncol. 1994 Oct;21(5):598-606. Semin Oncol. 1994. PMID: 7939750 Review. No abstract available.

3

Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Divgi CR, Kemeny N, Finn RD, Scott AM, Graham M, Germain JS, Richards EC, Larson SM, Oettgen HF, et al. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1994 Aug;12(8):1561-71. doi: 10.1200/JCO.1994.12.8.1561. J Clin Oncol. 1994. PMID: 8040668 Clinical Trial.

4

Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts.

Welt S, Divgi CR, Scott AM, Garin-Chesa P, Finn RD, Graham M, Carswell EA, Cohen A, Larson SM, Old LJ, et al. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1994 Jun;12(6):1193-203. doi: 10.1200/JCO.1994.12.6.1193. J Clin Oncol. 1994. PMID: 8201382 Clinical Trial.

5

Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.

Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ, et al. Oosterwijk E, et al. Among authors: larson sm. J Clin Oncol. 1993 Apr;11(4):738-50. doi: 10.1200/JCO.1993.11.4.738. J Clin Oncol. 1993. PMID: 8478666 Clinical Trial.

6

Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer.

Welt S, Scott AM, Divgi CR, Kemeny NE, Finn RD, Daghighian F, Germain JS, Richards EC, Larson SM, Old LJ. Welt S, et al. Among authors: larson sm. J Clin Oncol. 1996 Jun;14(6):1787-97. doi: 10.1200/JCO.1996.14.6.1787. J Clin Oncol. 1996. PMID: 8656247 Clinical Trial.

7

Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.

Macapinlac HA, Kemeny N, Daghighian F, Finn R, Zhang J, Humm J, Squire O, Larson SM. Macapinlac HA, et al. Among authors: larson sm. J Nucl Med. 1996 Apr;37(4 Suppl):25S-29S. J Nucl Med. 1996. PMID: 8676200 Clinical Trial.

8

Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liver.

Daghighian F, Humm JL, Macapinlac HA, Zhang J, Izzo J, Finn R, Kemeny N, Larson SM. Daghighian F, et al. Among authors: larson sm. J Nucl Med. 1996 Apr;37(4 Suppl):29S-32S. J Nucl Med. 1996. PMID: 8676201

9

Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody.

Daghighian F, Barendswaard E, Welt S, Humm J, Scott A, Willingham MC, McGuffie E, Old LJ, Larson SM. Daghighian F, et al. Among authors: larson sm. J Nucl Med. 1996 Jun;37(6):1052-7. J Nucl Med. 1996. PMID: 8683300 Free article.

10

Detection of bony metastases of androgen-independent prostate cancer by PET-FDG.

Yeh SD, Imbriaco M, Larson SM, Garza D, Zhang JJ, Kalaigian H, Finn RD, Reddy D, Horowitz SM, Goldsmith SJ, Scher HI. Yeh SD, et al. Among authors: larson sm. Nucl Med Biol. 1996 Aug;23(6):693-7. doi: 10.1016/0969-8051(96)00044-3. Nucl Med Biol. 1996. PMID: 8940712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

684 results

Search Page

Filters